Skip to main content

Table 1 Cumulative incidence rate (95% CI) for HSIL and ASCUS based on HPV mRNA status and HR-HPV DNA types at baseline

From: 14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology

CIR HPV RNA pos HPV mRNA neg HPV DNA 16/18 HPV DNA other than 16/18
HSIL positive 29.7% (24.8–30) 14.6% (13.3–22.7) 18.5% (13.2–23.7)
ASCUS positive 59.9% (57.3–66.2) 26.1% (16.5–35.9) 64.9% (47.5–72.9) 51.1% (43.1–63.8)
  1. ASCUS Atypical squamous cells of undetermined significance, HSIL high-grade squamous intraepithelial lesion, HR high risk
\